We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$1.4B
AUM Growth
-$416M
Cap. Flow
-$548M
Cap. Flow %
-39.01%
Top 10 Hldgs %
15.67%
Holding
242
New
35
Increased
45
Reduced
67
Closed
45

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$20.7M
2
CVX icon
Chevron
CVX
+$20.7M
3
STJ
St Jude Medical
STJ
+$20.3M
4
LH icon
Labcorp
LH
+$19.9M
5
MCD icon
McDonald's
MCD
+$19.2M

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$29.5M
2
CL icon
Colgate-Palmolive
CL
+$23.7M
3
GNRC icon
Generac Holdings
GNRC
+$23.2M
4
MUR icon
Murphy Oil
MUR
+$21.9M
5
MAT icon
Mattel
MAT
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 20.9%
2 Technology 18.98%
3 Consumer Discretionary 12.11%
4 Consumer Staples 9.66%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVT icon
26
Avnet
AVT
$7.12B
$17M 1.21%
+385,000
New +$15.9M
CA
27
DELISTED
CA, Inc.
CA
$16.5M 1.18%
491,000
+476,000
+3,173% +$15.1M
BBBY
28
DELISTED
Bed Bath & Beyond Inc
BBBY
$16.1M 1.14%
+200,000
New +$15.5M
ABBV icon
29
AbbVie
ABBV
$455B
$16M 1.14%
303,250
-100,000
-25% -$4.91M
AIZ icon
30
Assurant
AIZ
$14B
$15.4M 1.1%
232,000
-168,000
-42% -$10.3M
WRLD icon
31
World Acceptance Corp
WRLD
$840M
$15.2M 1.08%
174,000
-10,000
-5% -$933K
HAL icon
32
Halliburton
HAL
$26.4B
$15.2M 1.08%
300,000
– –
UTHR icon
33
United Therapeutics
UTHR
$26.2B
$15.2M 1.08%
134,000
-224,000
-63% -$20.2M
ITW icon
34
Illinois Tool Works
ITW
$81.6B
$14.7M 1.05%
175,000
+50,000
+40% +$3.94M
CLX icon
35
Clorox
CLX
$11.7B
$14.5M 1.03%
156,000
-198,000
-56% -$17.8M
OUTR
36
DELISTED
OUTERWALL INC
OUTR
$14.5M 1.03%
215,000
-35,000
-14% -$2.28M
MDT icon
37
Medtronic
MDT
$110B
$14.3M 1.02%
250,000
+45,000
+22% +$2.55M
SYNA icon
38
Synaptics
SYNA
$4.25B
$14.2M 1.01%
275,000
-210,000
-43% -$10.3M
B
39
Barrick Mining
B
$63.2B
$14.1M 1%
800,000
+650,000
+433% +$11.5M
STX icon
40
Seagate
STX
$193B
$14M 1%
+250,000
New +$12.4M
ELV icon
41
Elevance Health
ELV
$81.6B
$13.9M 0.99%
150,000
– –
BDX icon
42
Becton Dickinson
BDX
$45.6B
$13.8M 0.98%
128,125
+25,625
+25% +$2.66M
FSLR icon
43
First Solar
FSLR
$22.1B
$13.7M 0.97%
250,000
-250,000
-50% -$13.7M
PPL
44
PPL Corp
PPL
$26.8B
$13.5M 0.96%
483,144
+264,548
+121% +$7.46M
WAT icon
45
Waters Corp
WAT
$37.3B
$13.5M 0.96%
135,000
-3,000
-2% -$302K
ADBE icon
46
Adobe
ADBE
$98.5B
$13.5M 0.96%
225,000
-275,000
-55% -$15.2M
CTAS icon
47
Cintas
CTAS
$82.8B
$13.4M 0.96%
900,000
-700,000
-44% -$9.5M
WU icon
48
Western Union
WU
$2.4B
$13.4M 0.95%
775,000
+757,500
+4,329% +$13.3M
AVGO icon
49
Broadcom
AVGO
$1.85T
$13.2M 0.94%
+2,500,000
New +$11.5M
SUNE
50
DELISTED
SUNEDISON, INC COM
SUNE
$13.1M 0.93%
+1,000,000
New +$11.3M
1
2
3 4 5

Similar funds

CPIM
Coalescence Partners Investment Management New York $463M AUM 8.27% 1-Year Est. Return
SHWM
Smith & Howard Wealth Management Atlanta, Georgia $462M AUM 12.39% 1-Year Est. Return
CWWM
Clear Wave Wealth Management Red Bank, New Jersey $463M AUM
NG
NatWest Group Edinburgh, Scotland, United Kingdom $462M AUM 47.31% 1-Year Est. Return
PC
ParaFi Capital New York $462M AUM 12.81% 1-Year Est. Return
AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Hussman Strategic Advisors held 242 positions worth $1.4B, down 23% from $1.82B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hussman Strategic Advisors withdrew a net $548M in Q4 2013, closing 45 positions and reducing 67 holdings. Its most notable exit was Colgate-Palmolive, an estimated $23.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in St Jude Medical worth $21.7M.

  • Hussman Strategic Advisors's largest Q4 2013 buy was St Jude Medical: 350,000 shares worth $21.7M.
  • Hussman Strategic Advisors added most to GSK in Q4 2013, an estimated $20.7M increase.
  • Hussman Strategic Advisors's biggest Q4 2013 reduction was Aflac, cutting an estimated $29.5M.
  • Hussman Strategic Advisors fully exited Colgate-Palmolive in Q4 2013, selling an estimated $23.7M.
  • Hussman Strategic Advisors's ten largest holdings make up 16% of its $1.4B portfolio in Q4 2013.
  • Hussman Strategic Advisors opened 35 new positions and closed 45 in Q4 2013.
  • Hussman Strategic Advisors's portfolio value fell 23% quarter-over-quarter to $1.4B.

Based on Hussman Strategic Advisors's 13F filing for Q4 2013, filed 11 Feb 2014.